Lawrence M Alleva is Director of Mersana Therapeutics, Inc.. Currently has a direct ownership of 14,467 shares of MRSN, which is worth approximately $21,700. The most recent transaction as insider was on Jun 08, 2023, when has been sold 14,467 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.5K
0% 3M change
0% 12M change
Total Value Held $21,700

Lawrence M Alleva Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2023
BUY
Grant, award, or other acquisition
-
14,467 Added 50.0%
14,467 Common Stock

Also insider at

GRTX
Galera Therapeutics, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
BFAM
BRIGHT HORIZONS FAMILY SOLUTIONS INC. Consumer Cyclical
LMA

Lawrence M Alleva

Director
Malvern, PA

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Track Activities on MRSN